ScholarIQanswers from OpenAlex & ORCID
A.H. Jan Danser
ResearcherPublications, citations & collaboration network
A.H. Jan Danser is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does A.H. Jan Danser have?
ScholarIQindexed works
A.H. Jan Danser has 676 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does A.H. Jan Danser have?
ScholarIQcitation count
A.H. Jan Danser has 29,068 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of A.H. Jan Danser?
ScholarIQh-index
A.H. Jan Danser has an h-index of 87 in OpenAlex.
What is the i10-index of A.H. Jan Danser?
ScholarIQi10-index
A.H. Jan Danser has an i10-index of 376 in OpenAlex.
What is the ORCID of A.H. Jan Danser?
ScholarIQorcid
The ORCID for A.H. Jan Danser is on the source record.
What is the OpenAlex record for A.H. Jan Danser?
ScholarIQopenalex
The OpenAlex for A.H. Jan Danser is on the source record.
What are the most-cited papers on A.H. Jan Danser?
ScholarIQmost cited works
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, Michel Burnier, Guıdo Grassı, Andrzej Januszewicz, María Lorenza Muiesan, Konstantinos Tsioufis, Enrico Agabiti‐Rosei, Engi Algharably, Michel Azizi, Athanase Bénétos, Claudio Borghi, Jana Brguljan Hitij, Renata Cífková, António Coca, Véronique Cornelissen, Justin Cruickshank, Pedro Cunha, A.H. Jan Danser, Rosa de Pinho, Christian Delles, Anna F. Dominiczak, Maria Dorobanţu, Michalis Doumas, María S. Fernández‐Alfonso, Jean‐Michel Halimi, Zoltán Járai, Bojan Jelaković, Jens Jordan, Tatiana Kuznetsova, Stéphane Laurent, Dragan Lović, Empar Lurbe, Felix Mahfoud, Athanasios Manolis, Marius Miglinas, Krzysztof Narkiewicz, Teemu Niiranen, Paolo Palatini, Gianfranco Parati, Atul Pathak, Alexandre Persu, Jorge Polónia, Josep Redón, Pantelis Sarafidis, Roland E. Schmieder, Bart Spronck, Stella Stabouli, George S. Stergiou, Stefano Taddei, Costas Thomopoulos, Maciej Tomaszewski, Philippe van de Borne, Christoph Wanner, Thomas Weber, Bryan Williams, Zhen‐Yu Zhang, Sverre E. Kjeldsen
Angiotensin-Converting Enzyme in the Human Heart
A.H. Jan Danser, Maarten A.D.H. Schalekamp, Willem A. Bax, Antoinette MaassenVanDenBrink, Pramod R. Saxena, Günter A.J. Riegger, Heribert Schunkert
Hypertension
Luuk te Riet, Joep H.M. van Esch, Anton J.M. Roks, Anton H. van den Meiracker, A.H. Jan Danser
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
A.H. Jan Danser, Murray Epstein, Daniel Batlle
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Erik J.M. van Bommel, Marcel H.A. Muskiet, Michaël J.B. van Baar, Lennart Tonneijck, Mark M. Smits, Anna L. Emanuel, Andrea Božović, A.H. Jan Danser, Frank Geurts, Ewout J. Hoorn, Daan J. Touw, Emil List Larsen, Henrik E. Poulsen, Mark H.H. Kramer, Max Nieuwdorp, Jaap A. Joles, Daniël H. van Raalte